Anaphylaxis and insect allergy

@article{Demain2010AnaphylaxisAI,
  title={Anaphylaxis and insect allergy},
  author={Jeffrey G Demain and Ashley A Minaei and James M. Tracy},
  journal={Current Opinion in Allergy and Clinical Immunology},
  year={2010},
  volume={10},
  pages={318–322}
}
Purpose of reviewAnaphylaxis is an acute-onset and potentially life-threatening allergic reaction that can be caused by numerous allergic triggers including stinging insects. This review focuses on recent advances, natural history, risk factors and therapeutic considerations. Recent findingsRecent work suggests that concerns over insect allergy diagnosis continue to exist. This is especially true with individuals who have a convincing history of a serious life-threatening anaphylactic event… Expand
Insect anaphylaxis: addressing clinical challenges
TLDR
An evolving understanding should improve long-term management of insect anaphylaxis and help to better understand the clinical dilemma of appropriate management of the history-positive patient in which testing is unable to detect venom-specific IgE. Expand
Elevated baseline mast cell tryptase: a marker of severe insect venom anaphylaxis.
TLDR
A common theme that goes through these articles is the recent recognition of the clinical significance of elevated baseline tryptase levels in patients with severe anaphylaxis, which is likely to change clinical practice and may help clinicians identify patients at increased risk of fatal anAPHylaxis or nonresponse to insect venom immunotherapy. Expand
The Epidemiology of Anaphylaxis
TLDR
Interesting seasonal, geographic, and latitude differences have been observed in anaphylaxis prevalence and incidence rates, suggesting a possible role of vitamin D and sun exposure in modifying anAPHylaxis risk. Expand
Episodic hemorrhage during honeybee venom anaphylaxis: potential mechanisms.
TLDR
Melittin-free or recombinant allergens of HB venom, as well as modulators of the biochemical systems involved, could help to reduce the likelihood of hemorrhage, but further investigation is required before these strategies can be introduced in clinical practice. Expand
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
TLDR
This review assessed the clinical effectiveness and cost-effectiveness of Pharmalgen in providing immunotherapy to individuals with a history of type 1 [immunoglobulin E (IgE)-mediated] systemic allergic reaction to bee and wasp venom and found that PhVIT dominates. Expand
Risk Assessment of Hymenoptera Re-Sting Frequency: Implications for Decision-Making in Venom Immunotherapy
TLDR
The high degree of exposure of vespid- venom-allergic outdoor workers and bee-venom- allergic beekeepers and subjects living close to bee-houses underlines the high benefit of venom immunotherapy for these patients even if they suffered a non-life-threatening grade II reaction. Expand
Current challenges in molecular diagnostics of insect venom allergy
Background: Advanced component-resolved diagnostics (CRD) in Hymenoptera venom allergy (HVA) has improved the precise description of individual sensitization profiles. However, diagnostic gaps,Expand
Omalizumab beyond asthma.
TLDR
There is not enough evidence to support the regular use of omalizumab in IgE diseases other than asthma, however, some experimental and clinical investigations indicate that omalIZumab could be a therapeutic option in several allergic diseases like atopic dermatitis, urticaria, and eosinophilic gastrointestinal disorders. Expand
Current challenges in molecular diagnostics of insect venom allergy
TLDR
Clinical setting of basophil activation test (BAT) for routine diagnostics, venomic analysis for the identification of novel allergens and characterization of the molecular basis of cross-reactivity could be used to address major limitations and unresolved issues in molecular diagnostics of HVA. Expand
Allergy to hematophagous arthropod bites
TLDR
The immunological ingredients of this evolutionary interaction are discussed, which are mainly derived from a humoral immune response, and others based predominantly on T-lymphocyte-mediated hypersensitivities. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
Anaphylaxis: Recent advances in assessment and treatment.
  • F. Simons
  • Medicine
  • The Journal of allergy and clinical immunology
  • 2009
TLDR
Long-term risk reduction in patients with anaphylaxis focuses on optimal management of relevant comorbidities such as asthma and other respiratory diseases, cardiovascular disease, and mastocytosis or a clonal mast cell disorder; avoidance of the relevant confirmed allergen trigger; and relevant immunomodulation such as medication desensitization, venom immunotherapy, and possibly in the future, immunotherapy with food. Expand
Epidemiology of insect-venom anaphylaxis
TLDR
The epidemiological studies on sting anaphylaxis conducted in the 2000s continue to reveal the poor management of allergic patients and the startling lack of awareness of the efficacy of venom immunotherapy, indicating the urgent need to educate the general population and doctors on the management of venom-allergic patients. Expand
Epidemiology of anaphylaxis
TLDR
Increased knowledge of the epidemiology of anaphylaxis has provided insights into the characteristics of those patient groups most at risk of adverse outcomes, but these characteristics have poor specificity and limited applicability for detection of at-risk individuals in the clinical setting. Expand
Issues in stinging insect allergy immunotherapy: a review
  • I. Finegold
  • Medicine
  • Current opinion in allergy and clinical immunology
  • 2008
TLDR
The newest revision of the Immunotherapy Parameters provides much needed information concerning successful treatment with immunotherapy of Hymenoptera-sensitive patients. Expand
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.
TLDR
In patients with honeybee or vespid venom allergy, baseline serum tryptase concentrations are associated with the risk for severe anaphylactic reactions, and preventive measures should include substitution of angiotensin-converting enzyme inhibitors. Expand
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
TLDR
Based on the review, mastocytosis patients have a high risk of severe sting reactions in particular to yellow jacket and VIT could be suggested, so patients should be warned that the efficacy of VIT might be less than optimal and they should continue carrying two adrenaline auto injectors. Expand
The value of immunotherapy with venom in children with allergy to insect stings.
TLDR
It is concluded that venom immunotherapy is unnecessary for most children who are allergic to insect stings, as data confirm that immunotherapy with insect venom prevents recurrences of systemic reactions after subsequent insect stINGS. Expand
Risk assessment in anaphylaxis: current and future approaches.
TLDR
Algorithms have been developed for risk assessment of individuals with anaphylaxis, along with a research agenda for studies that could lead to an improved ability to confirm the clinical diagnosis of anAPHylaxis and to identify allergen-sensitized individuals who are at increased risk of anphylaxis. Expand
Epidemiology of anaphylaxis
  • P. Lieberman
  • Medicine
  • Current opinion in allergy and clinical immunology
  • 2008
TLDR
The exact incidence of anaphylaxis is unknown, but appears to be increasing, and the incidence is affected by geographical location, sex, atopy, and socioeconomic factors. Expand
Anaphylaxis epidemic: fact or fiction?
TLDR
In this issue of the Journal, in a retrospective population-based study, Decker et al report the incidence of anaphylaxis from 1990 to 2000 in Olmstead County, Minnesota, as 49.8/100,000 personyears, and note that during this decade, the incidence varied from year to year. Expand
...
1
2
3
4
5
...